{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:33:05Z","timestamp":1780360385498,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T00:00:00Z","timestamp":1393027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"DOI":"10.1007\/s00259-014-2703-0","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T16:46:18Z","timestamp":1393001178000},"source":"Crossref","is-referenced-by-count":6,"title":["Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin\u2019s lymphoma"],"prefix":"10.1007","author":[{"given":"Agostino","family":"Chiaravalloti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Danieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Abbatiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Travascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cantonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlio","family":"Guazzaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Orlacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Schillaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,22]]},"reference":[{"key":"2703_CR1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/annonc\/mdi200","volume":"16","author":"M Hutchings","year":"2005","unstructured":"Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Ann Oncol 2005;16:1160\u20138.","journal-title":"Ann Oncol"},{"key":"2703_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","volume":"107","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006;107:52\u20139.","journal-title":"Blood"},{"key":"2703_CR3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/annonc\/mdl122","volume":"17","author":"PL Zinzani","year":"2006","unstructured":"Zinzani PL, Tani M, Fanti S, Alinari L, Musuraca G, Marchi E, et al. Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin\u2019s disease patients. Ann Oncol 2006;17:1296\u2013300.","journal-title":"Ann Oncol"},{"key":"2703_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277\u2013300.","journal-title":"CA Cancer J Clin"},{"key":"2703_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ncponc1186","volume":"5","author":"AM Evens","year":"2008","unstructured":"Evens AM, Hutchings M, Diehl V. Treatment of Hodgkin lymphoma: the past, present, and future. Nat Clin Pract Oncol 2008;5:543\u201356.","journal-title":"Nat Clin Pract Oncol"},{"key":"2703_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1053-4296(96)80018-X","volume":"6","author":"SL Hancock","year":"1996","unstructured":"Hancock SL, Hoppe RT. Long-term complications of treatment and causes of mortality after Hodgkin\u2019s disease. Semin Radiat Oncol 1996;6:225\u201342.","journal-title":"Semin Radiat Oncol"},{"key":"2703_CR7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J Clin Oncol 1989;7:1630\u20136.","journal-title":"J Clin Oncol"},{"key":"2703_CR8","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3109\/10428190903308072","volume":"50","author":"A Gallamini","year":"2009","unstructured":"Gallamini A, Fiore F, Sorasio R, Meignan M. Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation. Leuk Lymphoma 2009;50:1761\u20134.","journal-title":"Leuk Lymphoma"},{"key":"2703_CR9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.112.110890","volume":"54","author":"A Biggi","year":"2013","unstructured":"Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M, et al. International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med 2013;54:683\u201390.","journal-title":"J Nucl Med"},{"key":"2703_CR10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/RLU.0b013e318263831d","volume":"37","author":"L Ceriani","year":"2012","unstructured":"Ceriani L, Suriano S, Ruberto T, Zucca E, Giovanella L. 18F-FDG uptake changes in liver and mediastinum during chemotherapy in patients with diffuse large B-cell lymphoma. Clin Nucl Med 2012;37:949\u201352.","journal-title":"Clin Nucl Med"},{"key":"2703_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2967\/jnumed.112.108530","volume":"54","author":"RR Boktor","year":"2013","unstructured":"Boktor RR, Walker G, Stacey R, Gledhill S, Pitman AG. Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET. J Nucl Med 2013;54:677\u201382.","journal-title":"J Nucl Med"},{"key":"2703_CR12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/RLU.0b013e3182872f0e","volume":"38","author":"D Groheux","year":"2013","unstructured":"Groheux D, Delord M, Rubello D, Colletti PM, Nguyen ML, Hindie E. Variation of liver SUV on (18)FDG-PET\/CT studies in women with breast cancer. Clin Nucl Med 2013;38:422\u20135.","journal-title":"Clin Nucl Med"},{"key":"2703_CR13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2141.2010.08485.x","volume":"152","author":"A Gallamini","year":"2011","unstructured":"Gallamini A, Patti C, Viviani S, Rossi A, Fiore F, Di Raimondo F, et al. Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses. Br J Haematol 2011;152:551\u201360.","journal-title":"Br J Haematol"},{"key":"2703_CR14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","volume":"37","author":"R Boellaard","year":"2010","unstructured":"Boellaard R, O\u2019Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010;37:181\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2703_CR15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s11547-009-0400-z","volume":"114","author":"O Schillaci","year":"2009","unstructured":"Schillaci O, Travascio L, Bolacchi F, Calabria F, Bruni C, Cicci\u00f2 C, et al. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients. Radiol Med 2009;114:890\u2013906.","journal-title":"Radiol Med"},{"key":"2703_CR16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-185X.2007.00027.x","volume":"82","author":"S Nakagawa","year":"2007","unstructured":"Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc 2007;82:591\u2013605.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"2703_CR17","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.","edition":"2"},{"key":"2703_CR18","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00330-009-1333-6","volume":"19","author":"PJ Robinson","year":"2009","unstructured":"Robinson PJ. The effects of cancer chemotherapy on liver imaging. Eur Radiol 2009;19:1752\u201362.","journal-title":"Eur Radiol"},{"key":"2703_CR19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM200205023461821","volume":"346","author":"GP Canellos","year":"2002","unstructured":"Canellos GP, Niedzwiecki D. Long-term follow-up of Hodgkin\u2019s disease trial. N Engl J Med 2002;346:1417\u20138.","journal-title":"N Engl J Med"},{"key":"2703_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/asheducation-2010.1.101","volume":"2010","author":"P Borchmann","year":"2010","unstructured":"Borchmann P, Engert A. The past: what we have learned in the last decade. Hematology Am Soc Hematol Educ Program 2010;2010:101\u20137.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2703_CR21","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/annonc\/mdh465","volume":"15","author":"A Rueda Dom\u00ednguez","year":"2004","unstructured":"Rueda Dom\u00ednguez A, M\u00e1rquez A, Gum\u00e1 J, Llanos M, Herrero J, de Las Nieves MA, et al. Treatment of stage I and II Hodgkin\u2019s lymphoma with ABVD chemotherapy: results after 7\u00a0years of a prospective study. Ann Oncol 2004;15:1798\u2013804.","journal-title":"Ann Oncol"},{"key":"2703_CR22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","volume":"363","author":"A Enger","year":"2010","unstructured":"Enger A, Pl\u00fctschow A, Eich HT, Lohri A, D\u00f6rken B, Borchmann P, et al. Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma. N Engl J Med 2010;363:640\u201352.","journal-title":"N Engl J Med"},{"key":"2703_CR23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/annonc\/mdl397","volume":"18","author":"E Boleti","year":"2007","unstructured":"Boleti E, Mead GM. ABVD for Hodgkin\u2019s lymphoma: full-dose chemotherapy without dose reductions or growth factors. Ann Oncol 2007;18:376\u201380.","journal-title":"Ann Oncol"},{"key":"2703_CR24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/annonc\/mdp331","volume":"21","author":"WS Owadally","year":"2010","unstructured":"Owadally WS, Sydes MR, Radford JA, Hancock BW, Cullen MH, Stenning SP, et al. Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519). Ann Oncol 2010;21:568\u201373.","journal-title":"Ann Oncol"},{"key":"2703_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MNM.0b013e32835aa7de","volume":"34","author":"A Chiaravalloti","year":"2013","unstructured":"Chiaravalloti A, Pagani M, Di Pietro B, Danieli R, Tavolozza M, Travascio L, et al. Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin\u2019s lymphoma? Nucl Med Commun 2013;34:57\u201363.","journal-title":"Nucl Med Commun"},{"key":"2703_CR26","first-page":"424","volume":"46","author":"CJ Jaskowiak","year":"2005","unstructured":"Jaskowiak CJ, Bianco JA, Perlman SB, Fine JP. Influence of reconstruction iterations on 18F-FDG PET\/CT standardized uptake values. J Nucl Med 2005;46:424\u20138.","journal-title":"J Nucl Med"},{"key":"2703_CR27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11307-008-0177-9","volume":"11","author":"BB Chin","year":"2009","unstructured":"Chin BB, Green ED, Turkington TG, Hawk TC, Coleman RE. Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3\u00a0h. Mol Imaging Biol 2009;11:118\u201322.","journal-title":"Mol Imaging Biol"},{"key":"2703_CR28","first-page":"26","volume":"32","author":"SM Batall\u00e9s","year":"2013","unstructured":"Batall\u00e9s SM, Villavicencio RL, Quaranta A, Burgos L, Trezzo S, Staffieri R, et al. Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies. Rev Esp Med Nucl Imagen Mol 2013;32:26\u201332.","journal-title":"Rev Esp Med Nucl Imagen Mol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2703-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-014-2703-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2703-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:16:36Z","timestamp":1565212596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-014-2703-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,22]]},"references-count":28,"alternative-id":["2703"],"URL":"https:\/\/doi.org\/10.1007\/s00259-014-2703-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,22]]}}}